NEW YORK (Reuters) – Substantial activity from the novel coronavirus combined with a major flu season this fall could place a tremendous burden on the healthcare system, a top U.S. health official said on Thursday.
The Centers for Disease Control and Prevention is seeking emergency use authorization for a test to detect and differentiate flu from COVID-19, the agency’s director Robert Redfield said in prepared testimony before a House of Representatives committee.
Redfield said the agency was working with manufacturers to maximize the availability of the influenza vaccine.
(Reporting by Michael Erman, writing by Lewis Krauskopf; Editing by Chizu Nomiyama)
